These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27657463)

  • 21. β-Blockers and ivabradine differentially affect cardiopulmonary function and left ventricular filling index.
    Fischer-Rasokat U; Honold J; Lochmann D; Wolter S; Liebetrau C; Fichtlscherer S; Möllmann H; Spyridopoulos I; Hamm CW
    Clin Res Cardiol; 2016 Jun; 105(6):527-34. PubMed ID: 26687495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ivabradine therapy to unmask heart rate-independent effects of β-blockers on pulse wave reflections.
    Fischer-Rasokat U; Honold J; Lochmann D; Liebetrau C; Leick J; Hamm C; Fichtlscherer S; Möllmann H; Spyridopoulos I
    Clin Res Cardiol; 2014 Jun; 103(6):487-94. PubMed ID: 24535377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ivabradine: a new frontier in the treatment of stable coronary artery disease and chronic heart failure.
    Gammone MA; Riccioni G; D'Orazio N
    Clin Ter; 2020; 171(5):e449-e453. PubMed ID: 32901791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of heart rate reduction by ivabradine on collateral function in patients with chronic stable coronary artery disease.
    Gloekler S; Traupe T; Stoller M; Schild D; Steck H; Khattab A; Vogel R; Seiler C
    Heart; 2014 Jan; 100(2):160-6. PubMed ID: 24186565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ivabradine in combination with beta-blocker reduces symptoms and improves quality of life in elderly patients with stable angina pectoris: age-related results from the ADDITIONS study.
    Müller-Werdan U; Stöckl G; Ebelt H; Nuding S; Höpfner F; Werdan K;
    Exp Gerontol; 2014 Nov; 59():34-41. PubMed ID: 25193811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single dose ivabradine versus intravenous metoprolol for heart rate reduction before coronary computed tomography angiography (CCTA) in patients receiving long-term calcium channel-blocker therapy.
    Celik O; Atasoy MM; Ertürk M; Yalçın AA; Aksu HU; Diker M; Aktürk IF; Atasoy I
    Acta Radiol; 2014 Jul; 55(6):676-81. PubMed ID: 24052362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rate control with ivabradine: angina pectoris and beyond.
    Parakh N; Bhargava B
    Am J Cardiovasc Drugs; 2011; 11(1):1-12. PubMed ID: 21090826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ivabradine versus metoprolol for heart rate reduction before coronary computed tomography angiography.
    Pichler P; Pichler-Cetin E; Vertesich M; Mendel H; Sochor H; Dock W; Syeda B
    Am J Cardiol; 2012 Jan; 109(2):169-73. PubMed ID: 22011557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heart Rate reduction by IVabradine for improvement of ENDothELial function in patients with coronary artery disease: the RIVENDEL study.
    Mangiacapra F; Colaiori I; Ricottini E; Balducci F; Creta A; Demartini C; Minotti G; Di Sciascio G
    Clin Res Cardiol; 2017 Jan; 106(1):69-75. PubMed ID: 27520989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the I(f) inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) study.
    Fox K; Ferrari R; Tendera M; Steg PG; Ford I;
    Am Heart J; 2006 Nov; 152(5):860-6. PubMed ID: 17070146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heart rate control with oral ivabradine in computed tomography coronary angiography: a randomized comparison of 7.5 mg vs 5 mg regimen.
    Guaricci AI; Maffei E; Brunetti ND; Montrone D; Di Biase L; Tedeschi C; Gentile G; Macarini L; Midiri M; Cademartiri F; Di Biase M
    Int J Cardiol; 2013 Sep; 168(1):362-8. PubMed ID: 23063141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: an analysis from the SIGNIFY study.
    Fox K; Ford I; Steg PG; Tardif JC; Tendera M; Ferrari R;
    Eur Heart J; 2015 Dec; 36(46):3291-6. PubMed ID: 26385957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial.
    Fox K; Ford I; Steg PG; Tendera M; Robertson M; Ferrari R;
    Eur Heart J; 2009 Oct; 30(19):2337-45. PubMed ID: 19720635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. I(f) inhibition in cardiovascular diseases.
    Thollon C; Vilaine JP
    Adv Pharmacol; 2010; 59():53-92. PubMed ID: 20933199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ivabradine reduces myocardial stunning in patients with exercise-inducible ischaemia.
    Maranta F; Tondi L; Agricola E; Margonato A; Rimoldi O; Camici PG
    Basic Res Cardiol; 2015 Nov; 110(6):55. PubMed ID: 26419678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous ivabradine for control of heart rate during coronary CT angiography: A randomized, double-blind, placebo-controlled trial.
    Cademartiri F; Garot J; Tendera M; Zamorano JL
    J Cardiovasc Comput Tomogr; 2015; 9(4):286-94. PubMed ID: 26088378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heart-Rate Reduction With Adjusted-Dose Ivabradine in Patients Undergoing Coronary Computed Tomographic Angiography: A Randomized Trial.
    Kacijan B; Novak Z; Jug B; Dolenc Novak M; Vrtovec M; Gužič Salobir B
    J Comput Assist Tomogr; 2017; 41(3):360-363. PubMed ID: 27861199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resting heart rate: risk indicator and emerging risk factor in cardiovascular disease.
    Böhm M; Reil JC; Deedwania P; Kim JB; Borer JS
    Am J Med; 2015 Mar; 128(3):219-28. PubMed ID: 25447617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antianginal Efficacy of Ivabradine in Patients With History of Coronary Revascularization.
    Zarifis J; Grammatikou V; Kallistratos M; Katsivas A
    Angiology; 2017 Jan; 68(1):10-18. PubMed ID: 26960667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of ivabradine in patients with coronary artery disease and left ventricular systolic dysfunction (from the BEAUTIFUL Holter Substudy).
    Tendera M; Talajic M; Robertson M; Tardif JC; Ferrari R; Ford I; Steg PG; Fox K;
    Am J Cardiol; 2011 Mar; 107(6):805-11. PubMed ID: 21247517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.